Changes in Red Cell Morphology and Haematological Laboratory Parameters Associated With Alectinib
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.25089
Abstract: Alectinib is a second‐generation anaplastic lymphoma kinase (ALK) inhibitor indicated for ALK‐mutated non‐small‐cell lung cancer. Recently, the association between alectinib and red cell morphological abnormalities has been reported in a few case series. This retrospective… read more here.
Keywords: laboratory; cell; changes red; red cell ... See more keywords